Arpan A Patel1, Anne M Walling2, Joni Ricks-Oddie3, Folasade P May4, Sammy Saab5, Neil Wenger6. 1. Division of Digestive Diseases, David Geffen School of Medicine at University of California, Los Angeles, California; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, California. Electronic address: ArpanPatel@mednet.ucla.edu. 2. Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, California; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California. 3. UCLA Institute for Digital Research and Education (IDRE), Statistical Consulting Group, Los Angeles, California. 4. Division of Digestive Diseases, David Geffen School of Medicine at University of California, Los Angeles, California; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California. 5. Division of Digestive Diseases, David Geffen School of Medicine at University of California, Los Angeles, California; Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, California. 6. Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, California.
Abstract
BACKGROUND & AIMS: There has been increased attention on ways to improve the quality of end-of-life care for patients with end-stage liver disease; however, there have been few reports of care experiences for patients during terminal hospitalizations. We analyzed data from a large national database to increase our understanding of palliative care for and health care utilization by patients with end-stage liver disease. METHODS: We performed a cross-sectional, observational study to examine terminal hospitalizations of adults with decompensated cirrhosis using data from the National Inpatient Sample from 2009 through 2013. We collected data on palliative care consultation and total hospital costs, and performed multivariate regression analyses to identify factors associated with palliative care consultation. We also investigated whether consultation was associated with lower costs. RESULTS: Among hospitalized adults with terminal decompensated cirrhosis, 30.3% received palliative care; the mean cost per hospitalization was $48,551 ± $1142. Palliative care consultation increased annually, and was provided to 18.0% of patients in 2009 and to 36.6% of patients in 2013 (P < .05). The mean cost for the terminal hospitalization did not increase significantly ($47,969 in 2009 to $48,956 in 2013, P = .77). African Americans, Hispanics, Asians, and liver transplant candidates were less likely to receive palliative care, whereas care in large urban teaching hospitals was associated with a higher odds of receiving consultation. Palliative care was associated with lower procedure burden-after adjusting for other factors, palliative care was associated with a cost reduction of $10,062. CONCLUSIONS: Palliative care consultation for patients with end-stage liver disease increased from 2009 through 2013. Palliative care consultation during terminal hospitalizations is associated with lower costs and procedure burden. Future research should evaluate timing and effects of palliative care on quality of end-of-life care in this population.
BACKGROUND & AIMS: There has been increased attention on ways to improve the quality of end-of-life care for patients with end-stage liver disease; however, there have been few reports of care experiences for patients during terminal hospitalizations. We analyzed data from a large national database to increase our understanding of palliative care for and health care utilization by patients with end-stage liver disease. METHODS: We performed a cross-sectional, observational study to examine terminal hospitalizations of adults with decompensated cirrhosis using data from the National Inpatient Sample from 2009 through 2013. We collected data on palliative care consultation and total hospital costs, and performed multivariate regression analyses to identify factors associated with palliative care consultation. We also investigated whether consultation was associated with lower costs. RESULTS: Among hospitalized adults with terminal decompensated cirrhosis, 30.3% received palliative care; the mean cost per hospitalization was $48,551 ± $1142. Palliative care consultation increased annually, and was provided to 18.0% of patients in 2009 and to 36.6% of patients in 2013 (P < .05). The mean cost for the terminal hospitalization did not increase significantly ($47,969 in 2009 to $48,956 in 2013, P = .77). African Americans, Hispanics, Asians, and liver transplant candidates were less likely to receive palliative care, whereas care in large urban teaching hospitals was associated with a higher odds of receiving consultation. Palliative care was associated with lower procedure burden-after adjusting for other factors, palliative care was associated with a cost reduction of $10,062. CONCLUSIONS: Palliative care consultation for patients with end-stage liver disease increased from 2009 through 2013. Palliative care consultation during terminal hospitalizations is associated with lower costs and procedure burden. Future research should evaluate timing and effects of palliative care on quality of end-of-life care in this population.
Authors: Irene J Higginson; Ilora Finlay; Danielle M Goodwin; Alison M Cook; Kerry Hood; Adrian G K Edwards; Hannah-Rose Douglas; Charles E Norman Journal: J Pain Symptom Manage Date: 2002-02 Impact factor: 3.612
Authors: Philip N Okafor; Derrick J Stobaugh; Augustine K Nnadi; Jayant A Talwalkar Journal: Am J Hosp Palliat Care Date: 2016-07-11 Impact factor: 2.500
Authors: David Casarett; Amy Pickard; F Amos Bailey; Christine Ritchie; Christian Furman; Ken Rosenfeld; Scott Shreve; Zhen Chen; Judy A Shea Journal: J Am Geriatr Soc Date: 2008-01-16 Impact factor: 5.562
Authors: Melissa W Wachterman; Corey Pilver; Dawn Smith; Mary Ersek; Stuart R Lipsitz; Nancy L Keating Journal: JAMA Intern Med Date: 2016-08-01 Impact factor: 21.873
Authors: Glenn Gade; Ingrid Venohr; Douglas Conner; Kathleen McGrady; Jeffrey Beane; Robert H Richardson; Marilyn P Williams; Marcia Liberson; Mark Blum; Richard Della Penna Journal: J Palliat Med Date: 2008-03 Impact factor: 2.947
Authors: Anne M Murray; Cheryl Arko; Shu-Cheng Chen; David T Gilbertson; Alvin H Moss Journal: Clin J Am Soc Nephrol Date: 2006-09-06 Impact factor: 8.237
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Nneka N Ufere; John Donlan; Lauren Waldman; Arpan Patel; Jules L Dienstag; Lawrence S Friedman; Kathleen E Corey; Nikroo Hashemi; Peter Carolan; Alan C Mullen; Michael Thiim; Irun Bhan; Ryan Nipp; Joseph Greer; Jennifer Temel; Raymond T Chung; Areej El-Jawahri Journal: Liver Transpl Date: 2019-05-03 Impact factor: 5.799
Authors: Nneka N Ufere; John Donlan; Lauren Waldman; Jules L Dienstag; Lawrence S Friedman; Kathleen E Corey; Nikroo Hashemi; Peter Carolan; Alan C Mullen; Michael Thiim; Irun Bhan; Ryan Nipp; Joseph A Greer; Jennifer S Temel; Raymond T Chung; Areej El-Jawahri Journal: Clin Gastroenterol Hepatol Date: 2019-03-15 Impact factor: 11.382
Authors: Nneka N Ufere; David L O'Riordan; Kara E Bischoff; Angela K Marks; Nwamaka Eneanya; Raymond T Chung; Vicki Jackson; Steven Z Pantilat; Areej El-Jawahri Journal: J Pain Symptom Manage Date: 2019-07-19 Impact factor: 3.612
Authors: Winnie Y Zou; Hashem B El-Serag; Yvonne H Sada; Sarah L Temple; Shubhada Sansgiry; Fasiha Kanwal; Jessica A Davila Journal: Dig Dis Sci Date: 2018-03-05 Impact factor: 3.199
Authors: Adeyinka Charles Adejumo; Donghee Kim; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; George Cholankeril; Robert J Wong; Paul Y Kwo; Aijaz Ahmed Journal: J Palliat Med Date: 2019-08-09 Impact factor: 2.947
Authors: Danielle R Heller; Raymond A Jean; Alexander S Chiu; Shelli I Feder; Vadim Kurbatov; Charles Cha; Sajid A Khan Journal: J Gastrointest Surg Date: 2018-09-04 Impact factor: 3.452
Authors: John H Holden; Hani Shamseddeen; Amy W Johnson; Benjamin Byriel; Kavitha Subramoney; Yao-Wen Cheng; Akira Saito; Marwan Ghabril; Naga Chalasani; Greg A Sachs; Eric S Orman Journal: J Palliat Med Date: 2020-02-24 Impact factor: 2.947